Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Point One | 2022 | Series B | $36.8M | Shenzhen |
| Ashermed | 2022 | Series B | $14.9M | Shanghai |
| Wuxi Vision Pro | 2022 | Series Unknown | $8.0M | Wuxi |
| Vistel | 2022 | Series B | Undisclosed | Haidian |
| Belief BioMed | 2022 | Series C | $120.0M | Minhang |
| Medilink Therapeutics | 2022 | Series B | $70.0M | Suzhou |
| BlockVision | 2022 | Seed | $5.0M | Singapore |
| Bouffalo Lab | 2022 | Series B | $30.0M | Shanghai |
| Clounix | 2022 | Series A | $63.2M | Hangzhou |
| Booming Technologies | 2022 | Series D | Undisclosed | Hangzhou |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 226 | Point One | Series B | $36.8M | Shenzhen, China |
| 227 | Ashermed | Series B | $14.9M | Shanghai, China |
| 228 | Wuxi Vision Pro | Series Unknown | $8.0M | Wuxi, China |
| 229 | Vistel | Series B | Undisclosed | Haidian, China |
| 230 | Belief BioMed | Series C | $120.0M | Minhang, China |
| 231 | Medilink Therapeutics | Series B | $70.0M | Suzhou, China |
| 232 | BlockVision | Seed | $5.0M | Singapore, Singapore |
| 233 | Bouffalo Lab | Series B | $30.0M | Shanghai, China |
| 234 | Clounix | Series A | $63.2M | Hangzhou, China |
| 235 | Booming Technologies | Series D | Undisclosed | Hangzhou, China |
Building the next-gen consumer products!
Ashermed is an CRO company that provides clinical research for pharmaceutical and device companies.
Wuxi Vision Pro is an emerging in ophthalmic materials and devices.
Vistel is a technology-based firm that focuses on the use of artificial intelligence (AI) in the medical field.
Belief BioMed focuses on gene therapy R&D, manufacturing, and clinical applications, specializing in novel AAV vectors.
Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.
BlockVision is a high-availability indexing network, supporting complex queries and data analysis.
Bouffalo Lab is a semiconductor chip design company that provides a full range of IoT solutions.
Clounix is a software startup that focuses on high-performance network chips and solutions.
Booming Tech is a cloud-based game and virtual reality platform that enables creators to innovate.
Xiaoniao Kuaiyan is a physical examination home service platform.
Deep View Technology is a motion capture and AR, VR application company.
EigenCOMM offers turnkey solutions for Internet of Things (IoT) ecosystems.
Yesmro is a leading MRO e-commerce company in China
Tungee is a professional sales intelligence solution provider.
PoPop World is a leisure playground with 20+ mini games.
WoXiaoYa is a food and beverage brand that makes and sells chidren's nutritional supplement products.
Clinflash is a prominent provider of cloud-based solutions and associated professional services in the field of clinical development.
Superhexa is a cutting-edge hardware firm that specializes in personal consumer electronics.
Yunji Technology is a Chinese robot company that builds a commercial service robot capable of delivering goods.
Wholee is a member-only zero-markup store.
Abogen Biosciences is a clinical stage biotechnology company focuses on developing nucleic acid-based RNA therapeutics.
Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.
ShanZhen provides access to affordable regular health checkups, as well as personalized health management plans and insurance.
YUANBAO TECH is a technology company in the field of network security.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Information Technology, Software, Health Care, 3D Technology. The firm invests across 56 different industry categories.
Among tracked funding rounds, Abogen Biosciences received $300.0M in a Series C round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include Point One, Ashermed, Wuxi Vision Pro, Vistel, Belief BioMed. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors